Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elyse C. Page
Observed names:
Elyse C Page,
Elyse Page,
Elyse. C. Page,
Page, Elyse
Institutions:
South Australian Health and Medical Research Institute,
Adelaide University,
The University of Adelaide
Observed institutions:
South Australian Health and Medical Research Institute,
Adelaide University,
The University of Adelaide
ORCID:
0000-0002-8990-2574
Observed ORCID:
0000-0002-8990-2574
OpenAlex ID:
A5069484473
HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort
2021
·
Elyse C. Page
, Susan L. Heatley
, et al.
·
Oncogene
·
32
Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
2021
·
Charlotte E. J. Downes
, Barbara J. McClure
, et al.
·
npj Precision Oncology
·
26
PDF
Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia
2021
·
Paniz Tavakoli Shirazi
, Laura N. Eadie
, et al.
·
Cancer Letters
·
19
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
2024
·
Laura N. Eadie
, Elias Lagonik
, et al.
·
Blood
·
15
PDF
Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression
2023
·
Elyse C. Page
, Susan L. Heatley
, et al.
·
Frontiers in Oncology
·
10
PDF
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients
2023
·
Ashlee J. Thomson
, Jacqueline A. Rehn
, et al.
·
Cancers
·
9
PDF
Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study
2026
·
Matthew Greenwood
, Shane Gangatharan
, et al.
·
HemaSphere
·
8
PDF
Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia
2022
·
Paniz Tavakoli Shirazi
, Laura N. Eadie
, et al.
·
Cancer Gene Therapy
·
7
Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients
2018
·
Elyse C. Page
, Susan L. Heatley
, et al.
·
Cancer Letters
·
7
Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain
2025
·
Elias Lagonik
, Elyse C. Page
, et al.
·
Blood Neoplasia
·
6
PDF
Asciminib Is Effective Against ABL1 Gene Fusions in Acute Lymphoblastic Leukemia but Only When the ABL1 SH3 Domain Is Present
2023
·
Laura N Eadie
, Caitlin E Schutz
, et al.
·
Blood
·
6
TP53 loss‑of‑function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137
2022
·
Michelle Forgione
, Barbara McClure
, et al.
·
Oncology Reports
·
5
PDF
Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol
2024
·
David T. Yeung
, Laura N. Eadie
, et al.
·
Blood Neoplasia
·
4
Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis
2022
·
Susan L. Heatley
, Elyse C. Page
, et al.
·
Frontiers in Oncology
·
3
PDF
The partner gene modulates response to asciminib in ABL1-rearranged Acute Lymphoblastic Leukemia
2026
·
Laura N. Eadie
, Daniel P. McDougal
, et al.
·
Neoplasia
·
2
Identification of a Novel, Oncogenic and Targetable TPR::ABL2 Fusion Gene in T‐Cell Acute Lymphoblastic Leukaemia
2026
·
Elias Lagonik
, Elyse. C. Page
, et al.
·
eJHaem
·
1
High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib
2025
·
Luke Quinlan
, Elyse C. Page
, et al.
·
Pediatric Blood & Cancer
·
1
Modeling Relapsed, Refractory Acute Lymphoblastic Leukemia from a Child with Neurofibromatosis
2021
·
Susan L Heatley
, Elyse C Page
, et al.
·
Blood
·
1
Metadata record for the article: Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
2021
·
Downes, Charlotte EJ
, McClure, Barbara J
, et al.
·
Figshare
·
1
Inducible Knockout of HMGN1 in an In Vivo xenograft Model Reduces Down Syndrome Leukemic Burden and Increases Survival Outcomes
2020
·
Elyse C Page
, Susan L Heatley
, et al.
·
Blood
·
1
Distinct asciminib sensitivity profiles between BCR::ABL1 p190 and p210 isoforms
2026
·
Elias Lagonik
, Luke J. Quinlan
, et al.
·
Experimental Hematology and Oncology
PDF
Distinct asciminib sensitivity profiles between BCR::ABL1 p190 and p210 isoforms
2026
·
Elias Lagonik
, Luke J. Quinlan
, et al.
·
Figshare
CEBP ‐altered B‐ALL: Two transcriptomic profiles across the age spectrum
2026
·
Jacqueline A. Rehn
, Ashlee J. Thomson‐Roberts
, et al.
·
HemaSphere
PDF
Improving Genomic Alignment Accuracy and Variant Detection for Acute Lymphoblastic Leukaemia Patients: A Pan-Genome Graph Approach
2026
·
Ashlee Thomson-Roberts
, Jacqueline Rehn
, et al.
·
Research Square
PDF
Clinical evidence and biological mechanisms linking obesity to adverse outcomes in pediatric and adolescent acute lymphoblastic leukemia
2026
·
Cate Cheney
, Elyse Page
, et al.
·
Frontiers in Oncology
PDF
Show more works
View as search
Works count:
35
Citation count:
164
H-index:
7
I10-index:
5
Year
Topic
Type